Kayentis
PrivateLast Round
Debt
Mar 28, 2023
Total Funding Raised
$22.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kayentis operates in Healthcare & Life Sciences and is based in Meylan. Its latest recorded funding round was a Debt round in March 2023.
Kayentis is a healthtech company that provides electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial (DCT) solutions for the collection of clinical trial data from patients and sites.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kayentis Comparables
Compare Kayentis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| YPrime | 91% | |
| Clinical Ink | 87% | |
| ObvioHealth | 86% |
For institutional investors. Book with your work email.
Kayentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 28, 2023 | ||||
| Growth Equity | Mar 28, 2023 | ||||
| Growth Equity | Dec 2, 2020 | ||||
| Growth Equity | Oct 10, 2016 | ||||
| VC Round | Feb 1, 2015 | ||||
Series C | Sep 1, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kayentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Capital | Growth Equity |
| Extens | Growth Equity, VC Round |
| LBO France | Growth Equity |
| Bpifrance | Growth Equity |
| Seventure Partners | Series C, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 62% MoM.
- Jan 1, 2025
Opened new office in Tokyo, adding to Grenoble and Boston locations.
For institutional investors. Book with your work email.
Kayentis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kayentis's valuation, stock price, and market status.
Is Kayentis a public or private company?
Kayentis is a private company.
What is the current stock price of Kayentis?
Kayentis is a private company, so its shares have no public market price. Caplight tracks Kayentis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kayentis worth (valuation)?
Valuation information for Kayentis is not publicly available.
Can I buy Kayentis stock?
Kayentis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kayentis's last funding round?
Kayentis's most recent funding round was Debt on March 28, 2023.
Who are the main investors in Kayentis?
Key investors in Kayentis include Innovation Capital, Extens, LBO France.
Will Kayentis IPO soon?
No public IPO plans have been announced for Kayentis.
How can I track Kayentis secondary market activity?
Caplight tracks bids, offers, and trades in Kayentis's shares on secondary markets.